Organogenesis Holdings Inc (NASDAQ: ORGO) on Tuesday, soared 7.04% from the previous trading day, before settling in for the closing price of $4.83. Within the past 52 weeks, ORGO’s price has moved between $2.61 and $7.08.
The company achieved an average annual earnings per share of 1617.00%. With a float of $58.86 million, this company’s outstanding shares have now reached $126.91 million.
Organogenesis Holdings Inc (ORGO) Insider Updates
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Organogenesis Holdings Inc is 53.62%, while institutional ownership is 54.13%. The most recent insider transaction that took place on Dec 16 ’25, was worth 1,021,241. Before that another transaction happened on Nov 26 ’25, when Company’s Director sold 187,957 for $5.29, making the entire transaction worth $994,293. This insider now owns 2,765,591 shares in total.
Organogenesis Holdings Inc (ORGO) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.07 earnings per share (EPS) for the period topping the consensus outlook (set at 0.02) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1617.00% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Organogenesis Holdings Inc (ORGO) is currently performing well based on its current performance indicators. A quick ratio of 2.88 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.10, a number that is poised to hit 0.22 in the next quarter and is forecasted to reach 0.18 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Organogenesis Holdings Inc (NASDAQ: ORGO) saw its 5-day average volume 2.18 million, a positive change from its year-to-date volume of 1.45 million. As of the previous 9 days, the stock’s Stochastic %D was 53.56%.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 45.47%, which indicates a significant decrease from 67.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was lower than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.77, while its 200-day Moving Average is $4.43. Nevertheless, the first resistance level for the watch stands at $5.38 in the near term. At $5.59, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.86. If the price goes on to break the first support level at $4.91, it is likely to go to the next support level at $4.64. Assuming the price breaks the second support level, the third support level stands at $4.43.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
Market capitalization of the company is 656.14 million based on 126,912K outstanding shares. Right now, sales total 482,040 K and income totals 860 K. The company made 150,860 K in profit during its latest quarter, and 21,570 K in sales during its previous quarter.
